Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-11-19A Randomized, Double-blind, Placebo-controlled Phase II/III Trial Evaluating the Efficacy and Safety of Sufenidone (SC1011) Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF).
-
CLINICAL_TRIALS study record update · 2024-11-04A Randomized, Double-blinded, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of SRN-001 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2024-10-31Determination of Functional Exercise Capacity, Peripheral Muscle Strength, Respiratory Muscle Endurance and Parameters Affecting Quality of Life in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-10-15The Special Drug Use-results Survey (All-Case Surveillance) of Ofev® Capsules in Patients With Idiopathic Pulmonary Fibrosis (IPF) in Japan
-
CLINICAL_TRIALS study record update · 2024-10-08Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-10-01Economic Burden Associated With Nintedanib Non-adherence Among Medicare Beneficiaries With IPF
-
CLINICAL_TRIALS study record update · 2024-09-19A Randomized, Open-Label, Two-Period, Double-Crossover Comparative Study on the Pharmacokinetics of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Chinese Subjects Under Fed Conditions
-
CLINICAL_TRIALS study record update · 2024-09-19A Randomized, Open-Label, Two-Period, Double-Crossover Comparative Study on the Pharmacokinetics of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Chinese Subjects Under Fed Conditions
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2024-09-19Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-08-30Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) : a Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-08-22An Active Surveillance to Monitor the Real World Safety in Indian Patients Prescribed Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-08-20The Assessment of Nutritional Status of Patients With IPF and The Effectiveness of Nutritional Support
-
CLINICAL_TRIALS study record update · 2024-08-16The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-08-15Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation. (REACT)
-
CLINICAL_TRIALS study record update · 2024-08-12Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2024-07-31Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
-
CLINICAL_TRIALS study record update · 2024-07-25Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-07-16The Relationship Between Pulmonary and Cardiac Dysfunction and the Cardiac Effects of Pulmonary Treatments: Cardiopulmonary MRI Analysis
-
CLINICAL_TRIALS study record update · 2024-07-09The Effect of Sodium Pyruvate Nasal Spray on Coughing in Patients With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-07-08A Phase 1, Randomized, Double Blinded, Placebo Controlled, First-in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of RSN0402 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-07-08An Open-label Clinical Study to Explore the Safety, Tolerability and Preliminary Efficacy of REGEND001 for Treatment of Idiopathic Pulmonary Fibrosis (IPF).
-
CLINICAL_TRIALS study record update · 2024-07-05Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2024-05-16A Double-blind, Randomized, Placebo-controlled Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of Oral AZD5055 Following Single and Multiple Ascending Doses
-
CLINICAL_TRIALS study record update · 2024-05-16A Phase III Open-label Extension Study to Evaluate Long-term Safety and Efficacy of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)